Consolidated Statements of Cash Flows (USD $)
3 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities:    
Net income (loss) $ 198,314 $ (50,234)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization 74,326 70,138
Common stock issued for services 10,308 8,114
Compensation expense recorded for stock options issued 15,905 18,259
Non-cash costs associated with exit or disposal activities   49,296
Changes in operating assets and liabilities:    
Trade and other receivables, net (431,032) (37,023)
Inventories (101,703) (27,440)
Prepaid expenses and other assets, net (54,028) (9,774)
Accounts payable 220,577 44,029
Accrued payroll and related liabilities (56,696) 12,531
Accrued interest and other liabilities (6,381) (58,343)
Net cash provided by (used in) operating activities (130,410) 19,553
Cash flows used in investing activities:    
Additions to equipment (14,265) (13,788)
Net cash used in investing activities (14,265) (13,788)
Cash flows provided by (used in) financing activities:    
Increase (decrease) in amount due to factor   (791,325)
Increase (decrease) in inventory loan   (163,460)
Proceeds from issuance of common stock, net of financing costs 134,268 533,998
Proceeds received from revolving line of credit 1,900,509 2,199,642
Payments on revolving line of credit (1,896,872) (1,377,589)
Payments on notes payable (18,116) (47,760)
Payments on capital lease obligations (26,198) (24,790)
Net cash provided by financing activities 93,591 328,716
Net increase (decrease) in cash and cash equivalents (51,084) 334,481
Cash and cash equivalents at beginning of period 1,248,537 1,095,239
Cash and cash equivalents at end of period 1,197,453 1,429,720
Supplemental cash flow disclosures:    
Cash paid for interest 6,423 62,743
Noncash investing and financing activities    
Accreted dividends on redeemable common and redeemable preferred stock $ 3,074 $ 5,078